29530050|t|Sulforaphane rescues amyloid-beta peptide-mediated decrease in MerTK expression through its anti-inflammatory effect in human THP-1 macrophages.
29530050|a|BACKGROUND: Mer tyrosine kinase (MerTK) activity necessary for amyloid-stimulated phagocytosis strongly implicates that MerTK dysregulation might contribute to chronic inflammation implicated in Alzheimer's disease (AD) pathology. However, the precise mechanism involved in the regulation of MerTK expression by amyloid-beta (Abeta) in proinflammatory environment has not yet been ascertained. METHODS: The objective of this study was to determine the underlying mechanism involved in Abeta-mediated decrease in MerTK expression through Abeta-mediated regulation of MerTK expression and its modulation by sulforaphane in human THP-1 macrophages challenged with Abeta1-42. We used protein preparation, Ca2+ influx fluorescence imaging, nuclear fractionation, Western blotting techniques, and small interfering RNA (siRNA) knockdown to perform our study. RESULTS: Abeta1-42 elicited a marked decrease in MerTK expression along with increased intracellular Ca2+ level and induction of proinflammatory cytokines such as IL-1beta and TNF-alpha. Ionomycin A and thapsigargin also increased intracellular Ca2+ levels and production of IL-1beta and TNF-alpha, mimicking the effect of Abeta1-42. In contrast, the Abeta1-42-evoked responses were attenuated by depletion of Ca2+ with ethylene glycol tetraacetic acid. Furthermore, recombinant IL-1beta or TNF-alpha elicited a decrease in MerTK expression. However, immunodepletion of IL-1beta or TNF-alpha with neutralizing antibodies significantly inhibited Abeta1-42-mediated downregulation of MerTK expression. Notably, sulforaphane treatment potently inhibited Abeta1-42-induced intracellular Ca2+ level and rescued the decrease in MerTK expression by blocking nuclear factor-kappaB (NF-kappaB) nuclear translocation, thereby decreasing IL-1beta and TNF-alpha production upon Abeta1-42 stimulation. Such adverse effects of sulforaphane were replicated by BAY 11-7082, a NF-kappaB inhibitor. Moreover, sulforaphane's anti-inflammatory effects on Abeta1-42-induced production of IL-1beta and TNF-alpha were significantly diminished by siRNA-mediated knockdown of MerTK, confirming a critical role of MerTK in suppressing Abeta1-42-induced innate immune response. CONCLUSION: These findings implicate that targeting of MerTK with phytochemical sulforaphane as a mechanism for preventing Abeta1-42-induced neuroinflammation has potential to be applied in AD therapeutics.
29530050	0	12	Sulforaphane	Chemical	MESH:C016766
29530050	21	33	amyloid-beta	Gene	351
29530050	63	68	MerTK	Gene	10461
29530050	97	109	inflammatory	Disease	MESH:D007249
29530050	120	125	human	Species	9606
29530050	126	131	THP-1	CellLine	CVCL:0006
29530050	157	176	Mer tyrosine kinase	Gene	10461
29530050	178	183	MerTK	Gene	10461
29530050	208	215	amyloid	Disease	MESH:C000718787
29530050	265	270	MerTK	Gene	10461
29530050	305	325	chronic inflammation	Disease	MESH:D007249
29530050	340	359	Alzheimer's disease	Disease	MESH:D000544
29530050	361	363	AD	Disease	MESH:D000544
29530050	437	442	MerTK	Gene	10461
29530050	457	469	amyloid-beta	Gene	351
29530050	471	476	Abeta	Gene	351
29530050	630	635	Abeta	Gene	351
29530050	657	662	MerTK	Gene	10461
29530050	682	687	Abeta	Gene	351
29530050	711	716	MerTK	Gene	10461
29530050	750	762	sulforaphane	Chemical	MESH:C016766
29530050	766	771	human	Species	9606
29530050	772	777	THP-1	CellLine	CVCL:0006
29530050	846	850	Ca2+	Chemical	-
29530050	1047	1052	MerTK	Gene	10461
29530050	1099	1103	Ca2+	Chemical	-
29530050	1161	1169	IL-1beta	Gene	3553
29530050	1174	1183	TNF-alpha	Gene	7124
29530050	1185	1196	Ionomycin A	Chemical	-
29530050	1201	1213	thapsigargin	Chemical	MESH:D019284
29530050	1243	1247	Ca2+	Chemical	-
29530050	1273	1281	IL-1beta	Gene	3553
29530050	1286	1295	TNF-alpha	Gene	7124
29530050	1408	1412	Ca2+	Chemical	-
29530050	1418	1450	ethylene glycol tetraacetic acid	Chemical	MESH:D004533
29530050	1477	1485	IL-1beta	Gene	3553
29530050	1489	1498	TNF-alpha	Gene	7124
29530050	1522	1527	MerTK	Gene	10461
29530050	1568	1576	IL-1beta	Gene	3553
29530050	1580	1589	TNF-alpha	Gene	7124
29530050	1680	1685	MerTK	Gene	10461
29530050	1707	1719	sulforaphane	Chemical	MESH:C016766
29530050	1781	1785	Ca2+	Chemical	-
29530050	1820	1825	MerTK	Gene	10461
29530050	1849	1870	nuclear factor-kappaB	Gene	4790
29530050	1872	1881	NF-kappaB	Gene	4790
29530050	1925	1933	IL-1beta	Gene	3553
29530050	1938	1947	TNF-alpha	Gene	7124
29530050	2011	2023	sulforaphane	Chemical	MESH:C016766
29530050	2043	2054	BAY 11-7082	Chemical	MESH:C434003
29530050	2058	2067	NF-kappaB	Gene	4790
29530050	2089	2101	sulforaphane	Chemical	MESH:C016766
29530050	2109	2121	inflammatory	Disease	MESH:D007249
29530050	2165	2173	IL-1beta	Gene	3553
29530050	2178	2187	TNF-alpha	Gene	7124
29530050	2249	2254	MerTK	Gene	10461
29530050	2286	2291	MerTK	Gene	10461
29530050	2404	2409	MerTK	Gene	10461
29530050	2429	2441	sulforaphane	Chemical	MESH:C016766
29530050	2490	2507	neuroinflammation	Disease	MESH:D000090862
29530050	2539	2541	AD	Disease	MESH:D000544
29530050	Negative_Correlation	10461	3553
29530050	Negative_Correlation	10461	4790
29530050	Negative_Correlation	MESH:C016766	7124
29530050	Positive_Correlation	MESH:D019284	3553
29530050	Positive_Correlation	10461	7124
29530050	Negative_Correlation	MESH:C016766	MESH:D007249
29530050	Negative_Correlation	MESH:C016766	4790
29530050	Association	4790	7124
29530050	Association	MESH:D007249	10461
29530050	Negative_Correlation	10461	351
29530050	Comparison	MESH:C016766	MESH:C434003
29530050	Association	MESH:D000544	10461
29530050	Negative_Correlation	MESH:C016766	351
29530050	Positive_Correlation	MESH:D019284	7124
29530050	Association	MESH:C000718787	10461
29530050	Negative_Correlation	MESH:C434003	4790
29530050	Negative_Correlation	MESH:C016766	3553
29530050	Negative_Correlation	MESH:C016766	10461

